Corneal Cross-Linking (CXL) for Keratoconus

What is corneal cross-linking?

Corneal cross-linking is a treatment designed to strengthen a weakened cornea. Riboflavin drops are applied to the cornea and activated with ultraviolet-A light, creating additional chemical bonds between collagen fibres in the stroma — similar in concept to how tanning hardens resin. The result is a stiffer cornea that better resists further bulging.

What CXL can and cannot do

Who may be considered for cross-linking?

\n
• Keratoconus with documented progression on serial topography/tomography
\n
• Younger patients, in whom progression is more likely
\n
• Post-LASIK ectasia (a related weakening), in selected cases
\n

How suitability is assessed

\n
• Pachymetry — the cornea must be thick enough for safe UV exposure; very thin corneas may need modified protocols or may not be suitable.
\n
• Topography/tomography — confirms the diagnosis and documents progression.
\n
• Corneal clarity — significant scarring may limit benefit and shift the discussion toward transplantation.
\n
• General eye health — active infection, severe dry eye or surface disease is treated first.
\n

The procedure in brief

\n
1. Anaesthetic drops numb the eye; the surface epithelium is usually removed (epi-off) or left intact (epi-on, in selected protocols).
\n
2. Riboflavin drops are applied until the stroma is saturated.
\n
3. The cornea is exposed to calibrated UV-A light for a set duration.
\n
4. A protective contact lens is placed while the surface heals.
\n

The procedure typically takes under an hour and is performed as a day procedure.

Recovery

\n
• Expect discomfort, watering and light sensitivity for the first few days (more with epi-off).
\n
• The protective lens is removed once the surface heals, usually within a week.
\n
• Vision fluctuates for weeks; stabilisation is judged over months on repeat maps.
\n
• Antibiotic and anti-inflammatory drops are used as prescribed; attend all reviews.
\n

Possible risks and limitations

\n
• Temporary corneal haze during healing; rarely persistent haze
\n
• Infection or delayed surface healing (uncommon)
\n
• Continued progression despite treatment in a minority of eyes — monitoring continues regardless
\n
• Very thin or scarred corneas may not be treatable
\n

After cross-linking

Once stability is confirmed, vision is optimised — often with speciality contact lenses — and maps are repeated periodically. Cross-linking does not remove the need for optical correction; it aims to protect the cornea from further change.

Information on this page is for general education and does not replace an examination, diagnosis or personalised medical advice from a qualified eye-care professional.

Related treatments & topics